TH002-01

N/A

Report date: 2025/02/20 16:25:15

Base Information

Drug NameTH002-01
Drug Alias NameTH002-01TH-002-01
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionB-cell maturation protein inhibitorsV-domain Ig suppressor of T-cell activation inhibitors
TargetsB-cell maturation proteinV-domain Ig suppressor of T-cell activation
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Bangentai Biomedical Tech Group Co Ltd
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A